Psychedelics, Equity, and Lessons from Cannabis: Building a Socially Just Future

The psychedelic research conducted at Johns Hopkins University and the social impact of cannabis legalization highlights important considerations for ensuring equitable outcomes as psychedelic therapies potentially become more widely available. Here are some key points to address the concerns about avoiding disproportionate criminalization of minorities and ensuring fair economic opportunities:

Lessons from Cannabis Legalization

Cannabis legalization efforts have revealed persistent racial disparities that must be addressed:

  • Despite similar usage rates, Black Americans are still arrested for cannabis offenses at nearly 4 times the rate of white Americans.
  • In many states that have legalized cannabis, racial disparities in arrests have changed little.
  • The legal cannabis industry has largely benefited white business owners, while many minorities have been excluded due to a lack of access to capital and other barriers.

Recommendations for Equitable Psychedelic Policy

To avoid repeating these inequities with psychedelics, policymakers and stakeholders should consider:

Criminal Justice Reform

  • Decriminalize possession and use of psychedelics to reduce arrests and incarceration.
  • Implement policies to narrow police discretion in stops and searches.
  • Retrain police departments to address biases and behaviors that contribute to racial disparities in enforcement.

Economic Opportunities

  • Create pathways for ownership and employment in the psychedelic industry for people of color and those with prior drug convictions.
  • Provide business consulting, access to capital, and ongoing support to help minority-owned businesses thrive long-term.

Community Reinvestment

  • Direct tax revenue from legal psychedelic sales towards programs that benefit communities most impacted by the War on Drugs.
  • Invest in education, mental health services, job training, and other initiatives to improve well-being in these communities.

Research and Treatment Access

  • Ensure clinical trials and research on psychedelic therapies include diverse participants.
  • Develop culturally-informed treatment protocols that consider the unique experiences of minority populations.
  • Create programs to increase affordability and access to psychedelic therapies for underserved communities.

Addressing Systemic Inequality

Recent research suggests that systemic racism and socioeconomic inequality may reduce the mental health benefits of psychedelics for minority populations. To address this:

  • Combine psychedelic therapies with broader efforts to combat systemic racism and inequality.
  • Develop integrated approaches that consider the impacts of trauma, stress, and discrimination on treatment outcomes.
  • Support research to better understand and mitigate factors that may diminish psychedelic benefits for minorities.

By learning from the shortcomings of cannabis legalization and proactively addressing issues of equity and access, the emerging field of psychedelic medicine has an opportunity to develop in a more socially just manner. This requires ongoing collaboration between researchers, policymakers, community leaders, and industry stakeholders to ensure that the potential benefits of psychedelic therapies are accessible to all, regardless of race or socioeconomic status.

Sources:

Is your company ready to address biases in generative AI?

Review our first-ever biases in generative AI insights report to learn how Better Together guides companies in creating powerful messages that spotlight their dedication to removing bias from generative AI.